Gold prices just lower; monthly gains on track
Director Kevin K. Gordon of Progyny, Inc. (NASDAQ:PGNY) sold 2,500 shares of common stock on August 11, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at a price of $22.035, for a total transaction value of $55087. The sale occurred as PGNY trades at $23.06, with a market capitalization of $1.98 billion. According to InvestingPro analysis, the company maintains strong financial health with a GREAT overall score.
Following the transaction, Gordon directly holds 8,026 shares of Progyny. In addition, 12,501 shares are held indirectly
In other recent news, Progyny Inc reported its second-quarter 2025 earnings, exceeding analysts’ expectations with an adjusted earnings per share of $0.48, well above the projected $0.16. The company also achieved a revenue of $332.9 million, surpassing forecasts and marking a year-over-year growth of 9.5%. Additionally, Cantor Fitzgerald reiterated its Overweight rating on Progyny stock, maintaining a price target of $28.00. The research firm expressed optimism about Progyny’s outlook for 2026, suggesting that the company’s recent selling season commentary could be a positive turning point for investor sentiment. These developments indicate a strong financial performance and continued confidence from analysts in the company’s future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.